Latest Nipro Corporation (NISOF) Headlines En
Post# of 3
Posted On: 03/10/2014 7:06:18 PM
Latest Nipro Corporation (NISOF) Headlines
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.
Global Prefilled Syringes Market to 2019: Glass Based and Plastic Based Analysis
M2 - Tue Feb 11, 10:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/lz4k3l/prefilled) has announced the addition of the "Global Prefilled Syringes Market to 2019: Glass Based and Plastic Based Analysis" report to their offering. The market for glass prefilled syringes is expected to lose some of its share at the end of the forecast period, which will be eaten up by the market for plastic syringes that will grow at a CAGR of 25% from 2013 to 2019. Prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market. This is mainly due to the various advantages associated with the use of prefilled syringes such as ease of administration, reduced risk of cross contamination, less overfill and ease of handling. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Rapid growth in the biologics market, technical advances in the sector and rising preference for self-administration using prefilled syringes, autoinjectors and pen injectors are the major factors driving growth of the global market for prefilled syringes. Currently more than 60% of the drugs under clinical development are biologics and are likely to be approved for parenteral administration. This is because most of the biologics including monoclonal antibodies, vaccines and anticoagulants, are large molecules which need to be administered via parenteral route to achieve the desired therapeutic effect. Likewise, technical advances related with siliconization and needlestick safety and prevention are also expected to drive growth of the market for prefilled syringes. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. Scope of the Report Segment - Glass Prefilled Syringes Market -- By Revenue (USD Million) -- By Volume (Million units) - Plastic Prefilled Syringes Market -- By Revenue (USD Million) -- By Volume (Million units) Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Prefilled Syringes Market Overview Chapter 4 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 Chapter 5 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/lz4k3l/prefilled
Nipro Medical Corporation Introduces State-of-the-Art ELISIO(TM) Polynephron(TM) Dialyzer
Marketwire - Thu Feb 06, 11:52AM CST
Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing, today announced the introduction of the ELISIO(TM) Polynephron(TM) Single Use, High-Flux, Hollow-Fiber Dialyzer. The ELISIO(TM) features a state-of-the-art Polynephron(TM) membrane similar in function to that of a human kidney delivering outstanding biocompatibility, hemocompatibility, and solute-removal performance, resulting in superior clearances for better patient outcomes. The ELISIO(TM) Polynephron Dialyzer has received 510(K) clearance from the U.S. Food and Drug Administration (FDA). The product is designed for the renal market, targeting those involved in care and procedures for kidney disease and dialysis.
Worldwide Dialysis Market Forecasts & Opportunities, 2018: Hemodialysis & Peritoneal Dialysis
M2 - Thu Jan 23, 9:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/7j7jdv/dialysis_market) has announced the addition of the "Worldwide Dialysis Market Forecasts & Opportunities, 2018: Hemodialysis & Peritoneal Dialysis" report to their offering. The global market is valued at $61.60 billion in 2013 and is expected to reach $83.20 billion by 2018, at a CAGR of 6.2% from 2013 to 2018. The global market has been segmented into two broad segments, namely, hemodialysis (HD) and peritoneal dialysis (PD). The hemodialysis segment is further categorized into HD products and HD services. The peritoneal dialysis segment is categorized into PD products and PD services. Furthermore, this report describes the HD and PD markets based on category. In this segment, the hemodialysis market includes center use hemodialysis and home hemodialysis. The peritoneal dialysis market is categorized into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent peritoneal dialysis (IPD), and PD Plus therapy. The CCPD segment holds the largest share of the peritoneal dialysis market in 2013 and is poised to grow at a CAGR of 8.2% in the forecast period. Based on the end users, the global market is segmented into in-center dialysis and home dialysis. A number of factors such as the increasing number of ESRD patients and the rising prevalence of diabetes and hypertension are driving the growth of the global market. Furthermore, growth in the number of dialysis facilities in developed as well as developing economies, growth in aging population, and increasing private investments and venture funding to support new product development are some of the other factors that are propelling the growth of the dialysis products and services market. In addition, increasing adoption of new treatment modalities such as home hemodialysis and nocturnal dialysis is further fuelling the growth of this market. However, a few pivotal factors such as the reduction in Medicare reimbursements to dialysis centers, low awareness about kidney diseases and their treatment modalities, product recalls, reuse of hemodialysis supplies, and poor reimbursement scenario in developing countries are hindering the growth of this market. Moreover, high competition among market players and low cost of kidney transplantation are the foremost challenges faced by industry players. Scope of the Report Global Hemodialysis Market - Products and Services - Hemodialysis Services -- In-center Hemodialysis services -- Home Hemodialysis Services - Hemodialysis Products -- Hemodialysis Machines --- Center Use Hemodialysis Machines --- Home Use Hemodialysis Machines -- Hemodialysis Consumables/supplies --- Dialyzers --- Hemodialysis Access Products --- Hemodialysis Bloodlines --- Hemodialysis Concentrates/dialysates --- Others Global Peritoneal Dialysis Market - Products and Services - Peritoneal Dialysis Products -- Peritoneal Dialysis Concentrates/dialysates -- Peritoneal Dialysis Machines -- Peritoneal Dialysis Catheters -- Peritoneal Dialysis Transfer Sets -- Other - Peritoneal Dialysis Services Category - Hemodialysis -- Center Use Hemodialysis -- Home Hemodialysis - Peritoneal Dialysis -- Continuous Cycling Peritoneal Dialysis (CCPD) -- Continuous Ambulatory Peritoneal Dialysis (CAPD) -- Intermittent PD (IPD) -- PD Plus Therapy End Users - In-center Dialysis -- Hospitals -- Independent Dialysis Centers - Home Dialysis -- Peritoneal Dialysis -- Home Hemodialysis Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Industry Analysis 5 Global Hemodialysis Market, By Products And Services 6 Global Peritoneal Dialysis Market, By Products And Services 7 Global Dialysis Market, By Category 8 Global Dialysis Market, By End Users 9 Global Dialysis Market, By Geography 10 Competitive Landscape 11 Company Profiles - Asahi Kasei Medical Co, Ltd - B Braun Melsungen Ag - Baxter International, Inc - Bellco SRL - Covidien, Plc - Davita Healthcare Partners, Inc - Diaverum Deutschland Gmbh - Fresenius Medical Care Ag & Co Kgaa - Gambro Ab - Kawasumi Laboratories, Inc - Medical Components, Inc - Medionics International, Inc - Nikkiso Co Ltd - Nipro Corporation - Nxstage Medical, Inc For more information visit http://www.researchandmarkets.com/research/7j...sis_market
Infraredx Announces Nipro Corporation's Plans for Commercial Manufacturing of TVC Imaging System in Japan
Business Wire - Thu Jan 16, 11:00AM CST
Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that Nipro Corporation, the exclusive distributor of the TVC Imaging System in Japan, has established a manufacturing subsidiary to commercially produce the TVC Imaging System. In 2012, the companies entered into a five-year distribution agreement and are on track to receive regulatory approval from Japan's Pharmaceuticals and Medical Device Agency (PMDA) in 2014. Last August, Infraredx received a $25 million equity investment from Nipro, and is slated to receive a minimum of $50 million in revenues during the duration of the five-year agreement.
2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018
M2 - Fri Jan 10, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/t8gg8c/nephrology_and) has announced the addition of the "2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018" report to their offering. Nephrology and urology devices are commonly used for treatment of kidney and urinary system related problems such as chronic kidney disease (CKD) and end stage renal disease (ESRD), kidney stone, benign prostatic hyperplasia (BPH), urinary incontinence and pelvic organ prolapse. A slow growing awareness of urinary diseases and causes of renal failure has led to a large population suffering from CKD, diabetes and ESRD. Growing market for dialysis due to rising incidences of chronic kidney diseases (CKD) along with increasing aging population is the major driver for this market. Increasing awareness about the benefits such as reduced treatment and recovery time among renal disease patients is also influencing the demand for nephrology and urology devices. Some other driving factors include innovation in urology devices, increasing healthcare spending and growing refurbished devices market particularly for lithotripters in Asia-Pacific and other developing regions. This also leaves consumers in Europe and North America to revamp their clinics and hospitals with new innovative technologies. Aging is the most common factor responsible for all types of urology diseases. It is expected that a large size of population will undergo kidney disease treatment which will increase the demand for these devices across the world. Key Topics Covered: 1 Preface 2 Executive Summary 3 Nephrology and Urology Devices Market Dynamics 4 Nephrology and Urology Devices Market, by Device Type 5 Nephrology and Urology Devices Market, by Geography 6 Market Share Analysis of Key Players, 2011 7 Company Profile Analysis Companies Mentioned: - Asahi Kasei Corp. - B Braun Group - Baxter International Inc. - C. R. Bard Inc. - Cook Group Incorporated - Dornier Medtech - Fresenius Medical Care - Nikkiso Co. Ltd. - Nipro Corporation - Nxstage Medical Inc - Rockwell Medical Technologies, Inc - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/t8...rology_and
Peripheral Vascular Stents - Global Analysis and Market Forecasts - 2013: The Iliac and Femoropopliteal Vascular Stent Markets Expected to Increase to Over $1 Billion By 2019
M2 - Wed Dec 04, 10:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/gtf7kg/medipoint) has announced the addition of the "MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts" report to their offering. Global Peripheral Vascular Stent Market Currently, BMS have the largest market share in the global peripheral vascular stent market for the lower extremity, followed by covered stents. The BMS market is an approximately $1.5 billion market that is more than three to 10 times the size of the covered and drug-eluting stent markets, respectively. Self-expanding nitinol stents account for over 60% of BMS used to treat iliac, femoropopliteal, and infrapopliteal artery lesions. Covered stents have been used for specific cases where the patient has good run-off, including treating atherosclerotic disease in the common iliac arteries and in-stent restenosis. Drug-eluting and bioabsorbable stent currently have the smallest market shares. However, as adoption of these stent technologies increases in the future, they will take market share away from bare metal and covered stents. Among the peripheral artery indications in the lower extremity, the iliac and femoropopliteal arteries currently have the largest market share in the peripheral vascular stent market. The iliac and femoropopliteal vascular stent markets are expected to increase to over $1 billion by 2019. Given the challenges in treating the femoropopliteal arteries, the femoropopliteal vascular stent market is an attractive market for drug-eluting and bioabsorbable stents. The adoption of stents for infrapopliteal lesions is lower than for iliac and femoropopliteal lesions. The iliac and femoropopliteal vascular stent markets are approximately three times the size of the infrapopliteal vascular stent market. Balloon angioplasty still remains the preferred method of treatment for treating infrapopliteal (below-the-knee [BTK]) lesions. Companies Mentioned: - Abbott Vascular - Amaranth Medical - Arterial Remodeling Technologies - Atrium Medical Corporation - Bard Peripheral Vascular (C.R. Bard) - Biotronik - Boston Scientific Corporation - 3D Biotek - 480 Biomedical - Cook Medical - Cordis Corporation (Johnson & Johnson) - CorInnova - Covidien - Cytograft Tissue Engineering - Flexible Stenting Solutions - IDEV Technologies - Kyoto Medical Planning - Medtronic - Nexeon Stent - Nipro Corporation - NovoStent Corporation - OptiMed - PeriTec Biosciences - Synergy Flow - Tepha - Terumo Corporation - TissueGen - Translumina - Vascular Concepts - Veryan Medical - VueKlar Cardiovascular - W.L. Gore & Associates - Zorion Medical For more information visit http://www.researchandmarkets.com/research/gtf7kg/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Dec 03, 3:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/hkbbts/prefilled) has announced the addition of the "Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Prefilled syringes constitute one of the fastest growing segments of the injectable drug delivery devices market. The various advantages associated with prefilled syringes over conventional delivery systems have been the primary foundation for their success to date and are expected to continue to drive market growth during the forecast period 2013 to 2019. These advantages include ease of administration, improved safety, reduced risk of contamination and accurate dosing. Depending on the type of material used to manufacture the syringe barrel, prefilled syringes are available mainly in two types, glass prefilled syringes and plastic (polymer) prefilled syringes. Although the industry is witnessing increasing use of polymer by many manufacturers for syringe manufacturing, glass is still considered as the gold standard and will continue to lead the market in terms of revenue as well as volume. This is attributed to the fact that changing the perception of manufacturers as well as healthcare practitioners from glass to plastic will be a gradual process. The market for glass prefilled syringes is expected to lose some of its share at the end of the forecast period, which will be eaten up by the market for plastic syringes that will grow at a CAGR of 25% from 2013 to 2019. Rapid growth in the biologics market, technical advances in the sector and rising preference for self-administration using prefilled syringes, autoinjectors and pen injectors are the major factors driving growth of the global market for prefilled syringes. Currently more than 60% of the drugs under clinical development are biologics and are likely to be approved for parenteral administration. This is because most of the biologics including monoclonal antibodies, vaccines and anticoagulants, are large molecules which need to be administered via parenteral route to achieve the desired therapeutic effect. Likewise, technical advances related with siliconization and needlestick safety and prevention are also expected to drive growth of the market for prefilled syringes. Europe claimed the largest regional share for prefilled syringes in terms of revenue as well as volume (unit consumption). However, during the forecast period, the North American market for prefilled syringes will exhibit the highest market growth at a CAGR of 15%. The Asia-Pacific region is more known as a follower rather than a leader in terms of development and adaptation of newer technologies. Becton, Dickinson & Company, Gerresheimer AG, Nipro Corporation, Schott AG and Stevanato Group are the key players dominating the global market for prefilled syringes. The top five market players together contributed to more than 85% of the total market revenue in 2012, indicating the oligopolistic nature of the competition in this market. Key Topics Covered 1 Preface 2 Executive Summary 3 Global Prefilled Syringes Market Overview 4 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 5 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 6 Competitive Landscape 7 Recommendations 8 Company Profiles Companies Mentioned - Baxter International, - Becton, Dickinson & Company - Bespak - Gerresheimer - Nipro - Schott - Stevanato - Unilife - Vetter Pharma International - West Pharmaceutical Services - Ypsomed Holding For more information visit http://www.researchandmarkets.com/research/hkbbts/prefilled About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Dialysis Market by Hemodialysis, Peritoneal Dialysis & End Users - Global Forecast to 2018
M2 - Wed Nov 20, 3:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/pds75f/dialysis_market) has announced the addition of the "Dialysis Market by Hemodialysis, Peritoneal Dialysis & End Users - Global Forecast to 2018" report to their offering. 'Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] - Global Forecast to 2018' The global market is broadly categorized into two segments, namely, hemodialysis (products & services) and peritoneal dialysis (products & services). The hemodialysis segment accounts for the larger share of the global market, while the peritoneal dialysis segment is expected to grow at a higher CAGR in the forecast period. The hemodialysis (HD) products and services market includes machines, consumables, and services. The peritoneal dialysis (PD) products and services market includes concentrates/dialysates, cyclers, catheters, transfer sets, accessories, and PD services. Moreover, the global market has also been classified on the basis of end users into in-center dialysis and home dialysis. The hemodialysis market is further segmented into center use HD and home HD. The peritoneal dialysis market is segmented into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent PD, and PD Plus therapy. The in-center dialysis end users market includes hospitals and independent dialysis centers; whereas, the home dialysis end users market includes peritoneal dialysis end users and home hemodialysis end users. Based on geography, the market is divided into North America, Asia-Pacific, Europe, and Rest of the World (RoW). In 2013, North America holds the largest share in the global market, followed by Asia-Pacific, Europe, and RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China, South Korea, India, and Rest of Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period. Factors such as the increasing number of independent dialysis centers, government initiatives to develop dialysis facilities, and increasing awareness about new dialysis treatment modalities are driving the growth of the market in the Asia-Pacific region. The major players in the market include Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical Components, Inc. (U.S.), Nikkiso Co. Ltd. (Japan), and NxStage Medical, Inc. (U.S.). Key Topics Covered: Introduction Executive Summary Market Overview Industry Analysis Global Hemodialysis Market, By Products And Services Global Peritoneal Dialysis Market, By Products And Services Global Dialysis Market, By Category Global Dialysis Market, By End Users Global Dialysis Market, By Geography Competitive Landscape Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* *Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies. List of Tables (147 Tables) List of Figures (77 Figures) For more information visit http://www.researchandmarkets.com/research/pd...sis_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Nephrology and Urology Devices Market Report - with Forecast to 2018
M2 - Mon Nov 04, 5:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/mlzms2/nephrology_and) has announced the addition of the "Global Nephrology and Urology Devices Market Report - with Forecast 2018" report to their offering. The study provides details of the nephrology and urology devices used for treatment of diseases of kidney and urinary system such as kidney and renal failure, urinary stone, benign prostatic hyperplasia (BPH), urinary incontinence and pelvic organ prolapse. The report also highlights role of endoscopy devices in nephrology and urology treatments. The study provides competitive analysis of various segments based on devices used for treatment of particular disease and of major geographical regions such as Asia-Pacific, Europe, North America and rest of the world. In-depth segmentation of market provides current trends and future outlook of technologies used in treatment of nephrology and urology devices. Key Topics Covered: 1 Preface 2 Executive Summary 2.1 Executive Summary 2.2 Comparative Analysis Of Nephrology And Urology Devices Market, By Geography 3 Nephrology and Urology Devices Market Dynamics 3.1 Introduction and Market Trends 3.2 Types Of Nephrology and Urology Diseases 3.3 Market Drivers 3.4 Market Restraints 3.5 Opportunities 3.6 Market Attractiveness for Nephrology &Urology Devices Market 3.7 Porters Five Forces Analysis for Nephrology &Urology Devices Market 4 Nephrology and Urology Devices Market, by Device Type 4.1 Nephrology and Urology Devices Market Overview 4.2 Dialysis Devices 4.3 Urinary Stone Treatment 4.4 Urinary Incontinence & Pelvic Organ Prolapse Treatment 4.5 Benign Prostatic Hyperplasia Devices 4.6 Endoscopy Devices 5 Nephrology and Urology Devices Market, by Geography 5.1 Market Overview 5.2 North America 5.3 Europe 5.4 Asia-Pacific 5.5 Rest Of The World (Row) 6 Market Share Analysis of Key Players 6.1 Market Share Analysis of Key Players 7 Company Profile Analysis Companies Mentioned - Asahi Kasei Corp. - B Braun Group - Baxter International Inc. - C. R. Bard Inc. - Cook Group Incorporated - Dornier Medtech - Fresenius Medical Care - Nikkiso Co. Ltd. - Nipro Corporation - Nxstage Medical Inc - Rockwell Medical Technologies, Inc - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/ml...rology_and
Infraredx Receives $25 Million Investment from Nipro Corporation
Business Wire - Wed Aug 21, 11:00PM CDT
Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that it has received a $25 million equity investment from Nipro Corporation. This investment builds on Infraredx's exclusive agreement with Nipro for distribution of its TVC Imaging System in Japan, the world's largest intravascular imaging market. In conjunction with the investment, a member of Nipro's management team will join Infraredx's board of directors.
The Global Infusion Pumps Market: A Comprehensive Analysis including Market Shares, Key Market and Product Segment Parameters, Competitive Position Maps, Market Conditions, Brands, Company Profiles and More
M2 - Fri Aug 02, 5:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/259wkv/infusion_pumps) has announced the addition of "The Global Infusion Pumps Market" report to their offering. The purpose of this report is to analyze and size the world market for Infusion Pumps Market. The report discusses key players and identifies trends impacting the market for these products. Topics covered include product definitions, strategies, competitive analysis, market shares, key market and product segment parameters, competitive position maps, market conditions, brands, and company profiles. Market Data: Revenues in US $, Unit Sales and ASPs. Estimates/ Forecasts for 2011-2018 by Product Segment: - By Material/ Application - Volumetric Pumps, Ambulatory Pumps, Insulin Pumps, Syringe Pumps, Implantable Pumps, Enteral Pumps - By Geographical location - US, Latam, Europe, Japan, ROAPAC and ROW - By Care Location - Acute Care, Alternate Care - By Transaction - Sale, Rental, Lease This report can help in: - Assessing the world market for infusion pumps, growth segments, and growth regions. - Understanding market drivers and restraints, and market segmentation and market shares and ranking. - Business planning, strategic decision making and competitive strategy. - Identifying opportunities for partnerships and alliances. Key Highlights: The Infusion Pumps Market is projected to reach over $7.6 billion by 2018. The most commonly used drug infusion pumps are seen in healthcare facilities; these range from large, volumetric pumps, ambulatory pumps, syringe pumps and enteral feeding pumps. Many compact portable models are also available for homecare and alternate care use. Individual-use, pumps that allow more independent and active lifestyles, include the wearable insulin pumps and implantable pumps The report on the worldwide market for Infusion Pumps discusses how growth in this market is shaped by trends in regulatory requirements, technology, clinical use, geographical variations and demographic factors, etc. Some of the issues highlighted in this report include: - Pump and administration set recalls, mandatory withdrawals and more stringent testing have impacted revenues from many well established brands and models of infusion pumps over the last few years. The US market has been the hardest hit. - The recent revenue impact while significant for certain product segments like volumetric and ambulatory pumps, is overshadowed by rising demand worldwide. - Volumetric pumps account for the largest share of revenues, while ambulatory pumps lead in unit sales. - In mature markets, sales of administration sets and other accessories is an important source of recurring revenue. - Highest overall growth is projected in the emerging markets of Asia and Latin America. - The insulin patch pump segment is currently the most dynamic in terms of innovation - Implantable pump segment is severely impacted in the short-term due to pump malfunction and recalls. - Syringe pumps will retain their foothold in all regional markets, and will be one of the highest growth segments on a global level. Companies Mentioned - AKAS Medical - ALCOR Scientific Inc. - Acacia Inc. - AngioDynamics - Animas Corp. - Arcomed AG - Ascor SA - Atom Medical Corporation - B Braun Melsungen AG - Baxter International Inc. - Beijing Rising Medical Co. Ltd. - CODAN Argus AG - CORPAK MedSystems Inc. - Caesarea Medical Electronics (CME) - Calibra Medical Inc. - Carefusion - Cellnovo Ltd. - Cequr SA - Contec Medical Systems Co.,Ltd. - Covidien - Daiken Medical Co. Ltd. - Daiwha Corporation Ltd. - DePuy/ Codman & Shurtleff Inc. - Debiotech SA - Emco Meditek Pvt Ltd. - Excelsior Medical Corp. - Expanding Industry Ltd. - Farafan Engineering Co. - Foures SA - Fresenius Kabi AG - GO Medical Industries Pty Ltd. - HK Surgical - Hospira Inc. - I-Flow LLC - IRadimed Corp. - Infus Medical (Thailand) Co Ltd. - Insulet Corp. - J-KEM Scientific Inc. - JMS Co Ltd. - Malem Medical Ltd. - Mammendorfer Institut f?r Physik und Medizin GmbH - MarCal Medical Inc. - Medima Ltd. - Medingo Ltd. - Medipacs Inc. - Medrad Inc. - Medtronic Inc. - Micrel Medical Devices S.A. - Moog Inc. - Nipro Corp. - Nouvag AG - Nutricia Clinical Care - RMS Medical products - Rising Medical Equipment Co. Ltd. - Roche Inc. - Ross Products/ Abbott Laboratories - Samtronic Industria e Comercio Ltda. - Sensile Medical AG - Shenzhen Shenke Medical Instrument Technical Development Co Ltd. - Smiths Medical - Sooil Development Co. Ltd. - Spring Health Solutions Ltd. - SteadyMed Therapeutics Inc. - Stryker Corp. - Summit Medical Products Inc. - Tandem Diabetes Care Inc. - Terumo Corp. - Tuta Healthcare Pty Ltd. - Universal Medical Technologies Inc. - Valeritas Inc. - Viltechmeda Ltd. - Wenzhou Jianda Medical Instrument Co. Ltd. - Woo Young Medical Co. Ltd. - Zoll Medical Corp. - Zyno Medical LLC For more information visit http://www.researchandmarkets.com/research/25...sion_pumps About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Thu Jul 18, 6:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zkjbs3/turkey_diabetes) has announced the addition of the "Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. "Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018", provides key market data on the market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - glucose monitoring and Insulin delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Key Topics Covered: 1.List of Tables 1.2 List of Figures 2 Introduction 2.1 What is This Report About? 3 Diabetes Care Devices In Turkey 3.1 Diabetes Care Devices, Turkey, Overall Revenue 3.2 Diabetes Care Devices, Turkey, Company Share 4 Glucose Monitoring In Turkey 4.1 Glucose Monitoring Overall Revenue 4.1.1 Blood Glucose Meters, Revenue 4.2 Glucose Monitoring Overall Volume 4.2.1 Blood Glucose Meters, Volume 4.3 Glucose Monitoring Average Price 4.4 Glucose Monitoring Distribution Share 4.5 Glucose Monitoring, Turkey, Company Share 5 Insulin Delivery In Turkey 5.1 Insulin Delivery Overall Revenue 5.1.1 Insulin Pens, Revenue 5.1.2 Insulin Pumps, Revenue 5.2 Insulin Delivery Overall Volume 5.2.1 Insulin Pens, Volume 5.2.2 Insulin Pumps, Volume 5.3 Insulin Delivery Average Price 5.4 Insulin Delivery Distribution Share 5.5 Insulin Delivery, Turkey, Company Share 6 Overview of Key Companies in Turkey Diabetes Care Devices Market 7 Appendix Companies Mentioned - Abbott Laboratories - Bayer HealthCare AG - Becton, Dickinson and Company - Eli Lilly and Company - F. Hoffmann-La Roche Ltd. - LifeScan, Inc. - Medtronic, Inc. - Nipro Corporation - Novo Nordisk A/S - Sanofi - Terumo Corporation - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/zk...y_diabetes
Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Tue Jul 09, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c8zmd9/switzerland) has announced the addition of the "Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Switzerland Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. Scope - Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery. - Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the two mar
Infusion Systems Market in Japan 2012-2016
M2 - Tue Jul 09, 9:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wvmbtc/infusion_systems) has announced the addition of the "Infusion Systems Market in Japan 2012-2016" report to their offering. Commenting on the report, an analyst from TechNavio's Healthcare team said: The Infusion Systems market in Japan has been witnessing an increasing preference for home healthcare. Hence, it is difficult for hospitals to arrange for a medical expert to be present with patients all the time to check that the patients are using the systems correctly. Therefore, to manage the infusion of therapeutic fluids, doctors are increasingly relying on remote monitoring infusion pumps. This is one of the major trends in the Infusion Systems market in Japan at present. According to the report, the increase in the prevalence of different chronic diseases such as AIDS and other hormonal disorders in Japan have led to an increase in the demand for infusion systems due to their capacity to deliver multiple functions. Similarly, the c
Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Tue Jun 11, 9:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4qlsdz/finland_diabetes) has announced the addition of the "Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. "Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Key Topics Covered: 1.1 List of Tables 5 1.2 List of Figures 6 2 Introduction 7 2.1
Baxter International Inc. Market Share Analysis
M2 - Mon Jun 10, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3d5vhh/baxter) has announced the addition of the "Baxter International Inc. Market Share Analysis" company profile to their offering. This report, Baxter International Inc. Market Share Analysis provides in-depth information on Baxter International Inc.'s market position in the different medical equipment markets it operates in. The report provides Baxter International Inc. market share information in six key market categories - Orthobiologics - Disposable Hospital Supplies - Wound Closure Devices - Renal Dialysis Equipment - Infusion Systems - Pain Management Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Global company shares (in Revenues) information for the key markets Baxter International Inc. operates in - Orthopedic Devices, Hospital Supplies, Wound Care Management, Nephrology and Urology Devices, Drug Delivery Devices and Anesthesia and Respiratory Devices - Baxter International Inc.'s company shares (in Revenues) information for all the key countries the company has presence in - Spain, Brazil, United Kingdom, Italy, France, Germany, United States, Japan, Australia, Canada, China and India. - Baxter International Inc.'s company shares (in Revenues) information for all the key market categories the company has presence in - Orthobiologics, Disposable Hospital Supplies, Wound Closure Devices, Renal Dialysis Equipment, Infusion Systems and Pain Management Devices. - All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa. - Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries. - The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in. - Comprehensive coverage of the latest financial deals involving the company and its subsidiaries. Companies Mentioned - Medtronic, Inc. - DePuy, Inc. - Genzyme Corporation - Synthes, Inc. - Biomet, Inc. - Smith & Nephew Plc - Seikagaku Corporation - DJO Finance LLC - Orthofix International N.V. - NuVasive, Inc. - Stryker Corporation - AlloSource - Wright Medical Group, Inc. - Globus Medical, Inc. - Anika Therapeutics, Inc. - Ferring International Center S.A. - Alphatec Holdings, Inc. - Adaptaide Inc. - RTI Biologics, Inc. - Exactech, Inc. - Japan Medical Dynamic Marketing, Inc. - Korea Bone Bank Inc. - KYOCERA Medical Corporation - Australian Biotechnologies - curasan AG - TRB Chemedica International S.A. - Bonovo Orthopedics, Inc. - Cardinal Health, Inc. - Molnlycke Health Care AB - 3M Health Care - Kimberly-Clark Corporation - Medline Industries, Inc. - Ansell Limited - Paul Hartmann AG - Becton, Dickinson and Company - B. Braun Melsungen AG - 3M Health Care Ltd. - Lifelong Meditech Ltd - Covidien plc - Ethicon, Inc. - Takeda Pharmaceuticals International GmbH - Lohmann & Rauscher GmbH & Co. KG - ConMed Corporation - Advanced Medical Solutions Group plc - Laboratoires Urgo S.A. - Derma Sciences, Inc. - Fresenius Medical Care AG & Co. KGaA - Gambro AB - Nipro Corporation - Asahi Kasei Corporation - Nikkiso Co., Ltd. - NxStage Medical, Inc. - Bellco Srl - Hospira, Inc. - CareFusion Corporation - Terumo Corporation - Fresenius Kabi AG - Smiths Medical - JMS Co., Ltd. - Codman & Shurtleff, Inc. - Universal Medical Technologies Inc. - Moog Inc. - Daiken Medical Co., Ltd. - TOP Corporation - Arcomed AG - Samtronic - Lifemed Ind. de Equipamentos e Art. Medicos Hospitalares S.A - Trivitron Healthcare Pvt Ltd. - Schiller Healthcare India Pvt. Ltd. - CME McKinley UK Limited - I-Flow Corporation For more information visit http://www.researchandmarkets.com/research/3d5vhh/baxter About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts
M2 - Fri Jun 07, 3:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ld9vk3/medipoint) has announced the addition of the "MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts" report to their offering. Scope - An overview of PAD, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized South America PVS market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018. - Investigation of current and future market competition for PVS - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the PVS sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists Reasons to Buy - Understand the trends shaping and driving South America PVS Market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in the US PVS Market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. Key Topics Covered 1 List of Tables and Figures 2 Introduction 3 Peripheral Artery Disease 4 Competitive Assessment 5 Unmet Needs 6 Pipeline Products 7 Clinical Trial Analysis 8 Industry Overview 9 Current and Future Players 10 Market Drivers, Opportunities and Barriers 11 Country Outlooks and Forecasts 12 Appendix Companies Mentioned - Abbott Vascular - Amaranth Medical - Arterial Remodeling Technologies - Atrium Medical Corporation - Bard Peripheral Vascular (C.R. Bard) - Biotronik - Boston Scientific Corporation - 3D Biotek - 480 Biomedical - Cook Medical - Cordis Corporation (Johnson & Johnson) - CorInnova - Covidien - Cytograft Tissue Engineering - Flexible Stenting Solutions - IDEV Technologies - Kyoto Medical Planning - Medtronic - Nexeon Stent - Nipro Corporation - NovoStent Corporation - OptiMed - PeriTec Biosciences - Synergy Flow - Tepha - Terumo Corporation - TissueGen - Translumina - Vascular Concepts - Veryan Medical - VueKlar Cardiovascular - W.L. Gore & Associates - Zorion Medical For more information visit http://www.researchandmarkets.com/research/ld9vk3/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts
M2 - Fri May 31, 5:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5kbwk8/medipoint) has announced the addition of the "MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts" report to their offering. Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone. This report looks at the current peripheral vascular stent market for the lower extremity in the five EU countries and evaluates the adoption and opportunities for this technology in these markets. Scope - An overview of PAD, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized EU PVS market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018. - Investigation of current and future
The Medical Device Market 2013: Japan
M2 - Wed May 08, 12:38PM CDT
Research and Markets (http://www.researchandmarkets.com/research/fldzzn/the_medical) has announced the addition of the "The Medical Device Market: Japan" report to their offering. Espicom's in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. Japan is the t
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.
Global Prefilled Syringes Market to 2019: Glass Based and Plastic Based Analysis
M2 - Tue Feb 11, 10:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/lz4k3l/prefilled) has announced the addition of the "Global Prefilled Syringes Market to 2019: Glass Based and Plastic Based Analysis" report to their offering. The market for glass prefilled syringes is expected to lose some of its share at the end of the forecast period, which will be eaten up by the market for plastic syringes that will grow at a CAGR of 25% from 2013 to 2019. Prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market. This is mainly due to the various advantages associated with the use of prefilled syringes such as ease of administration, reduced risk of cross contamination, less overfill and ease of handling. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Rapid growth in the biologics market, technical advances in the sector and rising preference for self-administration using prefilled syringes, autoinjectors and pen injectors are the major factors driving growth of the global market for prefilled syringes. Currently more than 60% of the drugs under clinical development are biologics and are likely to be approved for parenteral administration. This is because most of the biologics including monoclonal antibodies, vaccines and anticoagulants, are large molecules which need to be administered via parenteral route to achieve the desired therapeutic effect. Likewise, technical advances related with siliconization and needlestick safety and prevention are also expected to drive growth of the market for prefilled syringes. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. Scope of the Report Segment - Glass Prefilled Syringes Market -- By Revenue (USD Million) -- By Volume (Million units) - Plastic Prefilled Syringes Market -- By Revenue (USD Million) -- By Volume (Million units) Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Prefilled Syringes Market Overview Chapter 4 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 Chapter 5 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/lz4k3l/prefilled
Nipro Medical Corporation Introduces State-of-the-Art ELISIO(TM) Polynephron(TM) Dialyzer
Marketwire - Thu Feb 06, 11:52AM CST
Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing, today announced the introduction of the ELISIO(TM) Polynephron(TM) Single Use, High-Flux, Hollow-Fiber Dialyzer. The ELISIO(TM) features a state-of-the-art Polynephron(TM) membrane similar in function to that of a human kidney delivering outstanding biocompatibility, hemocompatibility, and solute-removal performance, resulting in superior clearances for better patient outcomes. The ELISIO(TM) Polynephron Dialyzer has received 510(K) clearance from the U.S. Food and Drug Administration (FDA). The product is designed for the renal market, targeting those involved in care and procedures for kidney disease and dialysis.
Worldwide Dialysis Market Forecasts & Opportunities, 2018: Hemodialysis & Peritoneal Dialysis
M2 - Thu Jan 23, 9:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/7j7jdv/dialysis_market) has announced the addition of the "Worldwide Dialysis Market Forecasts & Opportunities, 2018: Hemodialysis & Peritoneal Dialysis" report to their offering. The global market is valued at $61.60 billion in 2013 and is expected to reach $83.20 billion by 2018, at a CAGR of 6.2% from 2013 to 2018. The global market has been segmented into two broad segments, namely, hemodialysis (HD) and peritoneal dialysis (PD). The hemodialysis segment is further categorized into HD products and HD services. The peritoneal dialysis segment is categorized into PD products and PD services. Furthermore, this report describes the HD and PD markets based on category. In this segment, the hemodialysis market includes center use hemodialysis and home hemodialysis. The peritoneal dialysis market is categorized into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent peritoneal dialysis (IPD), and PD Plus therapy. The CCPD segment holds the largest share of the peritoneal dialysis market in 2013 and is poised to grow at a CAGR of 8.2% in the forecast period. Based on the end users, the global market is segmented into in-center dialysis and home dialysis. A number of factors such as the increasing number of ESRD patients and the rising prevalence of diabetes and hypertension are driving the growth of the global market. Furthermore, growth in the number of dialysis facilities in developed as well as developing economies, growth in aging population, and increasing private investments and venture funding to support new product development are some of the other factors that are propelling the growth of the dialysis products and services market. In addition, increasing adoption of new treatment modalities such as home hemodialysis and nocturnal dialysis is further fuelling the growth of this market. However, a few pivotal factors such as the reduction in Medicare reimbursements to dialysis centers, low awareness about kidney diseases and their treatment modalities, product recalls, reuse of hemodialysis supplies, and poor reimbursement scenario in developing countries are hindering the growth of this market. Moreover, high competition among market players and low cost of kidney transplantation are the foremost challenges faced by industry players. Scope of the Report Global Hemodialysis Market - Products and Services - Hemodialysis Services -- In-center Hemodialysis services -- Home Hemodialysis Services - Hemodialysis Products -- Hemodialysis Machines --- Center Use Hemodialysis Machines --- Home Use Hemodialysis Machines -- Hemodialysis Consumables/supplies --- Dialyzers --- Hemodialysis Access Products --- Hemodialysis Bloodlines --- Hemodialysis Concentrates/dialysates --- Others Global Peritoneal Dialysis Market - Products and Services - Peritoneal Dialysis Products -- Peritoneal Dialysis Concentrates/dialysates -- Peritoneal Dialysis Machines -- Peritoneal Dialysis Catheters -- Peritoneal Dialysis Transfer Sets -- Other - Peritoneal Dialysis Services Category - Hemodialysis -- Center Use Hemodialysis -- Home Hemodialysis - Peritoneal Dialysis -- Continuous Cycling Peritoneal Dialysis (CCPD) -- Continuous Ambulatory Peritoneal Dialysis (CAPD) -- Intermittent PD (IPD) -- PD Plus Therapy End Users - In-center Dialysis -- Hospitals -- Independent Dialysis Centers - Home Dialysis -- Peritoneal Dialysis -- Home Hemodialysis Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Industry Analysis 5 Global Hemodialysis Market, By Products And Services 6 Global Peritoneal Dialysis Market, By Products And Services 7 Global Dialysis Market, By Category 8 Global Dialysis Market, By End Users 9 Global Dialysis Market, By Geography 10 Competitive Landscape 11 Company Profiles - Asahi Kasei Medical Co, Ltd - B Braun Melsungen Ag - Baxter International, Inc - Bellco SRL - Covidien, Plc - Davita Healthcare Partners, Inc - Diaverum Deutschland Gmbh - Fresenius Medical Care Ag & Co Kgaa - Gambro Ab - Kawasumi Laboratories, Inc - Medical Components, Inc - Medionics International, Inc - Nikkiso Co Ltd - Nipro Corporation - Nxstage Medical, Inc For more information visit http://www.researchandmarkets.com/research/7j...sis_market
Infraredx Announces Nipro Corporation's Plans for Commercial Manufacturing of TVC Imaging System in Japan
Business Wire - Thu Jan 16, 11:00AM CST
Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that Nipro Corporation, the exclusive distributor of the TVC Imaging System in Japan, has established a manufacturing subsidiary to commercially produce the TVC Imaging System. In 2012, the companies entered into a five-year distribution agreement and are on track to receive regulatory approval from Japan's Pharmaceuticals and Medical Device Agency (PMDA) in 2014. Last August, Infraredx received a $25 million equity investment from Nipro, and is slated to receive a minimum of $50 million in revenues during the duration of the five-year agreement.
2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018
M2 - Fri Jan 10, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/t8gg8c/nephrology_and) has announced the addition of the "2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018" report to their offering. Nephrology and urology devices are commonly used for treatment of kidney and urinary system related problems such as chronic kidney disease (CKD) and end stage renal disease (ESRD), kidney stone, benign prostatic hyperplasia (BPH), urinary incontinence and pelvic organ prolapse. A slow growing awareness of urinary diseases and causes of renal failure has led to a large population suffering from CKD, diabetes and ESRD. Growing market for dialysis due to rising incidences of chronic kidney diseases (CKD) along with increasing aging population is the major driver for this market. Increasing awareness about the benefits such as reduced treatment and recovery time among renal disease patients is also influencing the demand for nephrology and urology devices. Some other driving factors include innovation in urology devices, increasing healthcare spending and growing refurbished devices market particularly for lithotripters in Asia-Pacific and other developing regions. This also leaves consumers in Europe and North America to revamp their clinics and hospitals with new innovative technologies. Aging is the most common factor responsible for all types of urology diseases. It is expected that a large size of population will undergo kidney disease treatment which will increase the demand for these devices across the world. Key Topics Covered: 1 Preface 2 Executive Summary 3 Nephrology and Urology Devices Market Dynamics 4 Nephrology and Urology Devices Market, by Device Type 5 Nephrology and Urology Devices Market, by Geography 6 Market Share Analysis of Key Players, 2011 7 Company Profile Analysis Companies Mentioned: - Asahi Kasei Corp. - B Braun Group - Baxter International Inc. - C. R. Bard Inc. - Cook Group Incorporated - Dornier Medtech - Fresenius Medical Care - Nikkiso Co. Ltd. - Nipro Corporation - Nxstage Medical Inc - Rockwell Medical Technologies, Inc - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/t8...rology_and
Peripheral Vascular Stents - Global Analysis and Market Forecasts - 2013: The Iliac and Femoropopliteal Vascular Stent Markets Expected to Increase to Over $1 Billion By 2019
M2 - Wed Dec 04, 10:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/gtf7kg/medipoint) has announced the addition of the "MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts" report to their offering. Global Peripheral Vascular Stent Market Currently, BMS have the largest market share in the global peripheral vascular stent market for the lower extremity, followed by covered stents. The BMS market is an approximately $1.5 billion market that is more than three to 10 times the size of the covered and drug-eluting stent markets, respectively. Self-expanding nitinol stents account for over 60% of BMS used to treat iliac, femoropopliteal, and infrapopliteal artery lesions. Covered stents have been used for specific cases where the patient has good run-off, including treating atherosclerotic disease in the common iliac arteries and in-stent restenosis. Drug-eluting and bioabsorbable stent currently have the smallest market shares. However, as adoption of these stent technologies increases in the future, they will take market share away from bare metal and covered stents. Among the peripheral artery indications in the lower extremity, the iliac and femoropopliteal arteries currently have the largest market share in the peripheral vascular stent market. The iliac and femoropopliteal vascular stent markets are expected to increase to over $1 billion by 2019. Given the challenges in treating the femoropopliteal arteries, the femoropopliteal vascular stent market is an attractive market for drug-eluting and bioabsorbable stents. The adoption of stents for infrapopliteal lesions is lower than for iliac and femoropopliteal lesions. The iliac and femoropopliteal vascular stent markets are approximately three times the size of the infrapopliteal vascular stent market. Balloon angioplasty still remains the preferred method of treatment for treating infrapopliteal (below-the-knee [BTK]) lesions. Companies Mentioned: - Abbott Vascular - Amaranth Medical - Arterial Remodeling Technologies - Atrium Medical Corporation - Bard Peripheral Vascular (C.R. Bard) - Biotronik - Boston Scientific Corporation - 3D Biotek - 480 Biomedical - Cook Medical - Cordis Corporation (Johnson & Johnson) - CorInnova - Covidien - Cytograft Tissue Engineering - Flexible Stenting Solutions - IDEV Technologies - Kyoto Medical Planning - Medtronic - Nexeon Stent - Nipro Corporation - NovoStent Corporation - OptiMed - PeriTec Biosciences - Synergy Flow - Tepha - Terumo Corporation - TissueGen - Translumina - Vascular Concepts - Veryan Medical - VueKlar Cardiovascular - W.L. Gore & Associates - Zorion Medical For more information visit http://www.researchandmarkets.com/research/gtf7kg/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Dec 03, 3:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/hkbbts/prefilled) has announced the addition of the "Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Prefilled syringes constitute one of the fastest growing segments of the injectable drug delivery devices market. The various advantages associated with prefilled syringes over conventional delivery systems have been the primary foundation for their success to date and are expected to continue to drive market growth during the forecast period 2013 to 2019. These advantages include ease of administration, improved safety, reduced risk of contamination and accurate dosing. Depending on the type of material used to manufacture the syringe barrel, prefilled syringes are available mainly in two types, glass prefilled syringes and plastic (polymer) prefilled syringes. Although the industry is witnessing increasing use of polymer by many manufacturers for syringe manufacturing, glass is still considered as the gold standard and will continue to lead the market in terms of revenue as well as volume. This is attributed to the fact that changing the perception of manufacturers as well as healthcare practitioners from glass to plastic will be a gradual process. The market for glass prefilled syringes is expected to lose some of its share at the end of the forecast period, which will be eaten up by the market for plastic syringes that will grow at a CAGR of 25% from 2013 to 2019. Rapid growth in the biologics market, technical advances in the sector and rising preference for self-administration using prefilled syringes, autoinjectors and pen injectors are the major factors driving growth of the global market for prefilled syringes. Currently more than 60% of the drugs under clinical development are biologics and are likely to be approved for parenteral administration. This is because most of the biologics including monoclonal antibodies, vaccines and anticoagulants, are large molecules which need to be administered via parenteral route to achieve the desired therapeutic effect. Likewise, technical advances related with siliconization and needlestick safety and prevention are also expected to drive growth of the market for prefilled syringes. Europe claimed the largest regional share for prefilled syringes in terms of revenue as well as volume (unit consumption). However, during the forecast period, the North American market for prefilled syringes will exhibit the highest market growth at a CAGR of 15%. The Asia-Pacific region is more known as a follower rather than a leader in terms of development and adaptation of newer technologies. Becton, Dickinson & Company, Gerresheimer AG, Nipro Corporation, Schott AG and Stevanato Group are the key players dominating the global market for prefilled syringes. The top five market players together contributed to more than 85% of the total market revenue in 2012, indicating the oligopolistic nature of the competition in this market. Key Topics Covered 1 Preface 2 Executive Summary 3 Global Prefilled Syringes Market Overview 4 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 5 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 6 Competitive Landscape 7 Recommendations 8 Company Profiles Companies Mentioned - Baxter International, - Becton, Dickinson & Company - Bespak - Gerresheimer - Nipro - Schott - Stevanato - Unilife - Vetter Pharma International - West Pharmaceutical Services - Ypsomed Holding For more information visit http://www.researchandmarkets.com/research/hkbbts/prefilled About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Dialysis Market by Hemodialysis, Peritoneal Dialysis & End Users - Global Forecast to 2018
M2 - Wed Nov 20, 3:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/pds75f/dialysis_market) has announced the addition of the "Dialysis Market by Hemodialysis, Peritoneal Dialysis & End Users - Global Forecast to 2018" report to their offering. 'Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] - Global Forecast to 2018' The global market is broadly categorized into two segments, namely, hemodialysis (products & services) and peritoneal dialysis (products & services). The hemodialysis segment accounts for the larger share of the global market, while the peritoneal dialysis segment is expected to grow at a higher CAGR in the forecast period. The hemodialysis (HD) products and services market includes machines, consumables, and services. The peritoneal dialysis (PD) products and services market includes concentrates/dialysates, cyclers, catheters, transfer sets, accessories, and PD services. Moreover, the global market has also been classified on the basis of end users into in-center dialysis and home dialysis. The hemodialysis market is further segmented into center use HD and home HD. The peritoneal dialysis market is segmented into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent PD, and PD Plus therapy. The in-center dialysis end users market includes hospitals and independent dialysis centers; whereas, the home dialysis end users market includes peritoneal dialysis end users and home hemodialysis end users. Based on geography, the market is divided into North America, Asia-Pacific, Europe, and Rest of the World (RoW). In 2013, North America holds the largest share in the global market, followed by Asia-Pacific, Europe, and RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China, South Korea, India, and Rest of Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period. Factors such as the increasing number of independent dialysis centers, government initiatives to develop dialysis facilities, and increasing awareness about new dialysis treatment modalities are driving the growth of the market in the Asia-Pacific region. The major players in the market include Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical Components, Inc. (U.S.), Nikkiso Co. Ltd. (Japan), and NxStage Medical, Inc. (U.S.). Key Topics Covered: Introduction Executive Summary Market Overview Industry Analysis Global Hemodialysis Market, By Products And Services Global Peritoneal Dialysis Market, By Products And Services Global Dialysis Market, By Category Global Dialysis Market, By End Users Global Dialysis Market, By Geography Competitive Landscape Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* *Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies. List of Tables (147 Tables) List of Figures (77 Figures) For more information visit http://www.researchandmarkets.com/research/pd...sis_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Nephrology and Urology Devices Market Report - with Forecast to 2018
M2 - Mon Nov 04, 5:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/mlzms2/nephrology_and) has announced the addition of the "Global Nephrology and Urology Devices Market Report - with Forecast 2018" report to their offering. The study provides details of the nephrology and urology devices used for treatment of diseases of kidney and urinary system such as kidney and renal failure, urinary stone, benign prostatic hyperplasia (BPH), urinary incontinence and pelvic organ prolapse. The report also highlights role of endoscopy devices in nephrology and urology treatments. The study provides competitive analysis of various segments based on devices used for treatment of particular disease and of major geographical regions such as Asia-Pacific, Europe, North America and rest of the world. In-depth segmentation of market provides current trends and future outlook of technologies used in treatment of nephrology and urology devices. Key Topics Covered: 1 Preface 2 Executive Summary 2.1 Executive Summary 2.2 Comparative Analysis Of Nephrology And Urology Devices Market, By Geography 3 Nephrology and Urology Devices Market Dynamics 3.1 Introduction and Market Trends 3.2 Types Of Nephrology and Urology Diseases 3.3 Market Drivers 3.4 Market Restraints 3.5 Opportunities 3.6 Market Attractiveness for Nephrology &Urology Devices Market 3.7 Porters Five Forces Analysis for Nephrology &Urology Devices Market 4 Nephrology and Urology Devices Market, by Device Type 4.1 Nephrology and Urology Devices Market Overview 4.2 Dialysis Devices 4.3 Urinary Stone Treatment 4.4 Urinary Incontinence & Pelvic Organ Prolapse Treatment 4.5 Benign Prostatic Hyperplasia Devices 4.6 Endoscopy Devices 5 Nephrology and Urology Devices Market, by Geography 5.1 Market Overview 5.2 North America 5.3 Europe 5.4 Asia-Pacific 5.5 Rest Of The World (Row) 6 Market Share Analysis of Key Players 6.1 Market Share Analysis of Key Players 7 Company Profile Analysis Companies Mentioned - Asahi Kasei Corp. - B Braun Group - Baxter International Inc. - C. R. Bard Inc. - Cook Group Incorporated - Dornier Medtech - Fresenius Medical Care - Nikkiso Co. Ltd. - Nipro Corporation - Nxstage Medical Inc - Rockwell Medical Technologies, Inc - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/ml...rology_and
Infraredx Receives $25 Million Investment from Nipro Corporation
Business Wire - Wed Aug 21, 11:00PM CDT
Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that it has received a $25 million equity investment from Nipro Corporation. This investment builds on Infraredx's exclusive agreement with Nipro for distribution of its TVC Imaging System in Japan, the world's largest intravascular imaging market. In conjunction with the investment, a member of Nipro's management team will join Infraredx's board of directors.
The Global Infusion Pumps Market: A Comprehensive Analysis including Market Shares, Key Market and Product Segment Parameters, Competitive Position Maps, Market Conditions, Brands, Company Profiles and More
M2 - Fri Aug 02, 5:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/259wkv/infusion_pumps) has announced the addition of "The Global Infusion Pumps Market" report to their offering. The purpose of this report is to analyze and size the world market for Infusion Pumps Market. The report discusses key players and identifies trends impacting the market for these products. Topics covered include product definitions, strategies, competitive analysis, market shares, key market and product segment parameters, competitive position maps, market conditions, brands, and company profiles. Market Data: Revenues in US $, Unit Sales and ASPs. Estimates/ Forecasts for 2011-2018 by Product Segment: - By Material/ Application - Volumetric Pumps, Ambulatory Pumps, Insulin Pumps, Syringe Pumps, Implantable Pumps, Enteral Pumps - By Geographical location - US, Latam, Europe, Japan, ROAPAC and ROW - By Care Location - Acute Care, Alternate Care - By Transaction - Sale, Rental, Lease This report can help in: - Assessing the world market for infusion pumps, growth segments, and growth regions. - Understanding market drivers and restraints, and market segmentation and market shares and ranking. - Business planning, strategic decision making and competitive strategy. - Identifying opportunities for partnerships and alliances. Key Highlights: The Infusion Pumps Market is projected to reach over $7.6 billion by 2018. The most commonly used drug infusion pumps are seen in healthcare facilities; these range from large, volumetric pumps, ambulatory pumps, syringe pumps and enteral feeding pumps. Many compact portable models are also available for homecare and alternate care use. Individual-use, pumps that allow more independent and active lifestyles, include the wearable insulin pumps and implantable pumps The report on the worldwide market for Infusion Pumps discusses how growth in this market is shaped by trends in regulatory requirements, technology, clinical use, geographical variations and demographic factors, etc. Some of the issues highlighted in this report include: - Pump and administration set recalls, mandatory withdrawals and more stringent testing have impacted revenues from many well established brands and models of infusion pumps over the last few years. The US market has been the hardest hit. - The recent revenue impact while significant for certain product segments like volumetric and ambulatory pumps, is overshadowed by rising demand worldwide. - Volumetric pumps account for the largest share of revenues, while ambulatory pumps lead in unit sales. - In mature markets, sales of administration sets and other accessories is an important source of recurring revenue. - Highest overall growth is projected in the emerging markets of Asia and Latin America. - The insulin patch pump segment is currently the most dynamic in terms of innovation - Implantable pump segment is severely impacted in the short-term due to pump malfunction and recalls. - Syringe pumps will retain their foothold in all regional markets, and will be one of the highest growth segments on a global level. Companies Mentioned - AKAS Medical - ALCOR Scientific Inc. - Acacia Inc. - AngioDynamics - Animas Corp. - Arcomed AG - Ascor SA - Atom Medical Corporation - B Braun Melsungen AG - Baxter International Inc. - Beijing Rising Medical Co. Ltd. - CODAN Argus AG - CORPAK MedSystems Inc. - Caesarea Medical Electronics (CME) - Calibra Medical Inc. - Carefusion - Cellnovo Ltd. - Cequr SA - Contec Medical Systems Co.,Ltd. - Covidien - Daiken Medical Co. Ltd. - Daiwha Corporation Ltd. - DePuy/ Codman & Shurtleff Inc. - Debiotech SA - Emco Meditek Pvt Ltd. - Excelsior Medical Corp. - Expanding Industry Ltd. - Farafan Engineering Co. - Foures SA - Fresenius Kabi AG - GO Medical Industries Pty Ltd. - HK Surgical - Hospira Inc. - I-Flow LLC - IRadimed Corp. - Infus Medical (Thailand) Co Ltd. - Insulet Corp. - J-KEM Scientific Inc. - JMS Co Ltd. - Malem Medical Ltd. - Mammendorfer Institut f?r Physik und Medizin GmbH - MarCal Medical Inc. - Medima Ltd. - Medingo Ltd. - Medipacs Inc. - Medrad Inc. - Medtronic Inc. - Micrel Medical Devices S.A. - Moog Inc. - Nipro Corp. - Nouvag AG - Nutricia Clinical Care - RMS Medical products - Rising Medical Equipment Co. Ltd. - Roche Inc. - Ross Products/ Abbott Laboratories - Samtronic Industria e Comercio Ltda. - Sensile Medical AG - Shenzhen Shenke Medical Instrument Technical Development Co Ltd. - Smiths Medical - Sooil Development Co. Ltd. - Spring Health Solutions Ltd. - SteadyMed Therapeutics Inc. - Stryker Corp. - Summit Medical Products Inc. - Tandem Diabetes Care Inc. - Terumo Corp. - Tuta Healthcare Pty Ltd. - Universal Medical Technologies Inc. - Valeritas Inc. - Viltechmeda Ltd. - Wenzhou Jianda Medical Instrument Co. Ltd. - Woo Young Medical Co. Ltd. - Zoll Medical Corp. - Zyno Medical LLC For more information visit http://www.researchandmarkets.com/research/25...sion_pumps About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Thu Jul 18, 6:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zkjbs3/turkey_diabetes) has announced the addition of the "Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. "Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018", provides key market data on the market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - glucose monitoring and Insulin delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Key Topics Covered: 1.List of Tables 1.2 List of Figures 2 Introduction 2.1 What is This Report About? 3 Diabetes Care Devices In Turkey 3.1 Diabetes Care Devices, Turkey, Overall Revenue 3.2 Diabetes Care Devices, Turkey, Company Share 4 Glucose Monitoring In Turkey 4.1 Glucose Monitoring Overall Revenue 4.1.1 Blood Glucose Meters, Revenue 4.2 Glucose Monitoring Overall Volume 4.2.1 Blood Glucose Meters, Volume 4.3 Glucose Monitoring Average Price 4.4 Glucose Monitoring Distribution Share 4.5 Glucose Monitoring, Turkey, Company Share 5 Insulin Delivery In Turkey 5.1 Insulin Delivery Overall Revenue 5.1.1 Insulin Pens, Revenue 5.1.2 Insulin Pumps, Revenue 5.2 Insulin Delivery Overall Volume 5.2.1 Insulin Pens, Volume 5.2.2 Insulin Pumps, Volume 5.3 Insulin Delivery Average Price 5.4 Insulin Delivery Distribution Share 5.5 Insulin Delivery, Turkey, Company Share 6 Overview of Key Companies in Turkey Diabetes Care Devices Market 7 Appendix Companies Mentioned - Abbott Laboratories - Bayer HealthCare AG - Becton, Dickinson and Company - Eli Lilly and Company - F. Hoffmann-La Roche Ltd. - LifeScan, Inc. - Medtronic, Inc. - Nipro Corporation - Novo Nordisk A/S - Sanofi - Terumo Corporation - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/zk...y_diabetes
Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Tue Jul 09, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c8zmd9/switzerland) has announced the addition of the "Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Switzerland Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. Scope - Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery. - Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the two mar
Infusion Systems Market in Japan 2012-2016
M2 - Tue Jul 09, 9:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wvmbtc/infusion_systems) has announced the addition of the "Infusion Systems Market in Japan 2012-2016" report to their offering. Commenting on the report, an analyst from TechNavio's Healthcare team said: The Infusion Systems market in Japan has been witnessing an increasing preference for home healthcare. Hence, it is difficult for hospitals to arrange for a medical expert to be present with patients all the time to check that the patients are using the systems correctly. Therefore, to manage the infusion of therapeutic fluids, doctors are increasingly relying on remote monitoring infusion pumps. This is one of the major trends in the Infusion Systems market in Japan at present. According to the report, the increase in the prevalence of different chronic diseases such as AIDS and other hormonal disorders in Japan have led to an increase in the demand for infusion systems due to their capacity to deliver multiple functions. Similarly, the c
Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Tue Jun 11, 9:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4qlsdz/finland_diabetes) has announced the addition of the "Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. "Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Key Topics Covered: 1.1 List of Tables 5 1.2 List of Figures 6 2 Introduction 7 2.1
Baxter International Inc. Market Share Analysis
M2 - Mon Jun 10, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3d5vhh/baxter) has announced the addition of the "Baxter International Inc. Market Share Analysis" company profile to their offering. This report, Baxter International Inc. Market Share Analysis provides in-depth information on Baxter International Inc.'s market position in the different medical equipment markets it operates in. The report provides Baxter International Inc. market share information in six key market categories - Orthobiologics - Disposable Hospital Supplies - Wound Closure Devices - Renal Dialysis Equipment - Infusion Systems - Pain Management Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Global company shares (in Revenues) information for the key markets Baxter International Inc. operates in - Orthopedic Devices, Hospital Supplies, Wound Care Management, Nephrology and Urology Devices, Drug Delivery Devices and Anesthesia and Respiratory Devices - Baxter International Inc.'s company shares (in Revenues) information for all the key countries the company has presence in - Spain, Brazil, United Kingdom, Italy, France, Germany, United States, Japan, Australia, Canada, China and India. - Baxter International Inc.'s company shares (in Revenues) information for all the key market categories the company has presence in - Orthobiologics, Disposable Hospital Supplies, Wound Closure Devices, Renal Dialysis Equipment, Infusion Systems and Pain Management Devices. - All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa. - Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries. - The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in. - Comprehensive coverage of the latest financial deals involving the company and its subsidiaries. Companies Mentioned - Medtronic, Inc. - DePuy, Inc. - Genzyme Corporation - Synthes, Inc. - Biomet, Inc. - Smith & Nephew Plc - Seikagaku Corporation - DJO Finance LLC - Orthofix International N.V. - NuVasive, Inc. - Stryker Corporation - AlloSource - Wright Medical Group, Inc. - Globus Medical, Inc. - Anika Therapeutics, Inc. - Ferring International Center S.A. - Alphatec Holdings, Inc. - Adaptaide Inc. - RTI Biologics, Inc. - Exactech, Inc. - Japan Medical Dynamic Marketing, Inc. - Korea Bone Bank Inc. - KYOCERA Medical Corporation - Australian Biotechnologies - curasan AG - TRB Chemedica International S.A. - Bonovo Orthopedics, Inc. - Cardinal Health, Inc. - Molnlycke Health Care AB - 3M Health Care - Kimberly-Clark Corporation - Medline Industries, Inc. - Ansell Limited - Paul Hartmann AG - Becton, Dickinson and Company - B. Braun Melsungen AG - 3M Health Care Ltd. - Lifelong Meditech Ltd - Covidien plc - Ethicon, Inc. - Takeda Pharmaceuticals International GmbH - Lohmann & Rauscher GmbH & Co. KG - ConMed Corporation - Advanced Medical Solutions Group plc - Laboratoires Urgo S.A. - Derma Sciences, Inc. - Fresenius Medical Care AG & Co. KGaA - Gambro AB - Nipro Corporation - Asahi Kasei Corporation - Nikkiso Co., Ltd. - NxStage Medical, Inc. - Bellco Srl - Hospira, Inc. - CareFusion Corporation - Terumo Corporation - Fresenius Kabi AG - Smiths Medical - JMS Co., Ltd. - Codman & Shurtleff, Inc. - Universal Medical Technologies Inc. - Moog Inc. - Daiken Medical Co., Ltd. - TOP Corporation - Arcomed AG - Samtronic - Lifemed Ind. de Equipamentos e Art. Medicos Hospitalares S.A - Trivitron Healthcare Pvt Ltd. - Schiller Healthcare India Pvt. Ltd. - CME McKinley UK Limited - I-Flow Corporation For more information visit http://www.researchandmarkets.com/research/3d5vhh/baxter About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts
M2 - Fri Jun 07, 3:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ld9vk3/medipoint) has announced the addition of the "MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts" report to their offering. Scope - An overview of PAD, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized South America PVS market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018. - Investigation of current and future market competition for PVS - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the PVS sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists Reasons to Buy - Understand the trends shaping and driving South America PVS Market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in the US PVS Market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. Key Topics Covered 1 List of Tables and Figures 2 Introduction 3 Peripheral Artery Disease 4 Competitive Assessment 5 Unmet Needs 6 Pipeline Products 7 Clinical Trial Analysis 8 Industry Overview 9 Current and Future Players 10 Market Drivers, Opportunities and Barriers 11 Country Outlooks and Forecasts 12 Appendix Companies Mentioned - Abbott Vascular - Amaranth Medical - Arterial Remodeling Technologies - Atrium Medical Corporation - Bard Peripheral Vascular (C.R. Bard) - Biotronik - Boston Scientific Corporation - 3D Biotek - 480 Biomedical - Cook Medical - Cordis Corporation (Johnson & Johnson) - CorInnova - Covidien - Cytograft Tissue Engineering - Flexible Stenting Solutions - IDEV Technologies - Kyoto Medical Planning - Medtronic - Nexeon Stent - Nipro Corporation - NovoStent Corporation - OptiMed - PeriTec Biosciences - Synergy Flow - Tepha - Terumo Corporation - TissueGen - Translumina - Vascular Concepts - Veryan Medical - VueKlar Cardiovascular - W.L. Gore & Associates - Zorion Medical For more information visit http://www.researchandmarkets.com/research/ld9vk3/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts
M2 - Fri May 31, 5:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5kbwk8/medipoint) has announced the addition of the "MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts" report to their offering. Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone. This report looks at the current peripheral vascular stent market for the lower extremity in the five EU countries and evaluates the adoption and opportunities for this technology in these markets. Scope - An overview of PAD, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized EU PVS market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018. - Investigation of current and future
The Medical Device Market 2013: Japan
M2 - Wed May 08, 12:38PM CDT
Research and Markets (http://www.researchandmarkets.com/research/fldzzn/the_medical) has announced the addition of the "The Medical Device Market: Japan" report to their offering. Espicom's in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. Japan is the t
(0)
(0)Nipro Corp. (NISOF) Stock Research Links
Scroll down for more posts ▼